Oxford Gene Technology (OGT) and Integrated Genomics (IG) have announced the signing of a collaboration to develop and market a Pichia pastoris gene expression (GE) oligonucleotide microarray
The collaboration gives OGT access to IG's proprietary Pichia pastoris genomic sequence for the design and development of a high quality optimised 60-mer oligonucleotide microarray using the ink jet in-situ synthesis (Ijiss) platform.
OGT will market the array worldwide, and offer a sample analysis service at its Oxford laboratory.
James Clough, commercial director at OGT, said: "We are delighted to be working with Integrated Genomics.
"The combination of OGT's oligonucleotide array expertise combined with Integrated Genomics sequence and detailed Pichia genome annotations will be a powerful molecular research tool for the Pichia community and add strength to our growing portfolio".
Theresa Walunas, vice president of Integrated Genomics added: "OGT's Ijiss technology provides an important new capability to the Pichia research community.
"Microarrays will allow researchers to understand how Pichia's gene expression changes in response to genetic modifications."
